SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-002254
Filing Date
2017-02-13
Accepted
2017-02-13 17:16:31
Documents
3
Period of Report
2017-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20170213_8k.htm 8-K 15771
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 15535
3 aviragen.jpg GRAPHIC 9151
  Complete submission text file 0001437749-17-002254.txt   45446
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 17600675
SIC: 2836 Biological Products, (No Diagnostic Substances)